DOI.org (Crossref) , Chedid, V., et al
An oral format removes the biggest adoption barrier for patients who are hesitant about injectable drugs like Zepbound or Mounjaro
Attract more patients actively searching for GLP1 treatments, Semaglutide, Tirzepatide, or bariatric surgery
Weve seen other drugs successfully serve as a runway for behavior changes
How the Program Works Begin with a telehealth or in-person visit with our clinical team to review your goals, health history, medications, and any contraindications
It is intended for researchers, laboratories, research organisations and procurement buyers reviewing bulk-style Retatrutide product formats for controlled laboratory research environments